Cell-printed 3D liver-on-a-chip possessing a liver microenvironment and biliary system
Source abstract
Abstract
Abstract To overcome the drawbacks of in vitro liver testing during drug development, numerous liver-on-a-chip models have been developed. However, current liver-on-a-chip technologies are labor-intensive, lack extracellular matrix (ECM) essential for liver cells, and lack a biliary system essential for excreting bile acids, which contribute to intestinal digestion but are known to be toxic to hepatocytes. Therefore, fabrication methods for development of liver-on-a-chip models that overcome the above limitations are required. Cell-printing technology enables construction of complex 3D structures with multiple cell types and biomaterials. We used cell-printing to develop a 3D liver-on-a-chip with multiple cell types for co-culture of liver cells, liver decellularized ECM bioink for a 3D microenvironment, and vascular/biliary fluidic channels for creating vascular and biliary systems. A chip with a biliary fluidic channel induced better biliary system creation and liver-specific gene expression and functions compared to a chip without a biliary system. Further, the 3D liver-on-a-chip showed better functionalities than 2D or 3D cultures. The chip was evaluated using acetaminophen and it showed an effective drug response. In summary, our results demonstrate that the 3D liver-on-a-chip we developed is promising in vitro liver test platform for drug discovery.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Liver physiology and pathology · Pluripotent Stem Cells Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Evaluation of antiretrovirals in animal models of HIV infection10.1016/j.antiviral.2009.07.008 ↗
2. Organ-on-a-chip devices advance to market10.1039/C6LC01554A ↗
3. Organ-on-a-chip for assessing environmental toxicants10.1016/j.copbio.2016.11.019 ↗
4. Convergence of regenerative medicine and synthetic biology to develop standardized and validated models of human diseases with clinical relevance10.1016/j.copbio.2015.06.001 ↗
5. Three dimensional spheroid cell culture for nanoparticle safety testing10.1016/j.jbiotec.2015.01.001 ↗
6. The present and future role of microfluidics in biomedical research10.1038/nature13118 ↗
7. Organ-on-a-chip platforms for studying drug delivery systems10.1016/j.jconrel.2014.05.004 ↗
8. Liver development in zebrafish (Danio rerio)10.1016/S1673-8527(08)60121-6 ↗
9. Chip-based liver equivalents for toxicity testing-organotypicalness versus cost-efficient high throughput10.1039/c3lc50240f ↗
10. An artificial liver sinusoid with a microfluidic endothelial‐like barrier for primary hepatocyte culture10.1002/bit.21360 ↗
11. Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip10.1039/C6LC01374K ↗
12. Long‐term maintenance of a microfluidic 3D human liver sinusoid10.1002/bit.25700 ↗
13. Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte–hepatic stellate cell interactions and flow effects10.1039/c3lc50197c ↗
14. A liver-on-a-chip platform with bioprinted hepatic spheroids10.1088/1758-5090/8/1/014101 ↗
15. Microfluidic cell culture systems for cellular analysis
16. Microfluidic cell culture10.1016/j.copbio.2013.10.005 ↗
17. Microfluidic synthesis of pure chitosan microfibers for bio-artificial liver chip10.1039/b924987g ↗
18. Construction of a liver sinusoid based on the laminar flow on chip and self-assembly of endothelial cells10.1088/1758-5090/aaa97e ↗
19. Long-term cultivation of HepG2 liver cells encapsulated in alginate hydrogels: a study of cell viability, morphology and drug metabolism10.1016/j.tiv.2010.02.015 ↗
20. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues10.1038/nmat3357 ↗
21. Engineering liver therapies for the future10.1089/10763270260424097 ↗
22. Advances in bioartificial liver devices10.1053/jhep.2001.26753 ↗
23. The role of bile salts in digestion10.1016/j.cis.2010.12.002 ↗
24. Solid freeform fabrication technology applied to tissue engineering with various biomaterials10.1039/C1SM06863F ↗
25. 3D printed tissue models: present and future10.1021/acsbiomaterials.6b00129 ↗
26. One-step fabrication of an organ-on-a-chip with spatial heterogeneity using a 3D bioprinting technology10.1039/C6LC00450D ↗
27. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix10.1038/nm.2170 ↗
28. Bioengineered transplantable porcine livers with re-endothelialized vasculature10.1016/j.biomaterials.2014.11.027 ↗
29. Liver extracellular matrix providing dual functions of two-dimensional substrate coating and three-dimensional injectable hydrogel platform for liver tissue engineering10.1021/bm4015039 ↗
30. Development of liver decellularized extracellular matrix bioink for three-dimensional cell printing-based liver tissue engineering10.1021/acs.biomac.6b01908 ↗
31. Microfluidic blood–brain barrier model provides in vivo‐like barrier properties for drug permeability screening10.1002/bit.26045 ↗
32. Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line10.1093/toxsci/kfs122 ↗
33. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies10.1093/toxsci/kft021 ↗
34. Variations in the vascular and biliary structures of the liver: a comprehensive anatomical study10.1080/00015458.2018.1438565 ↗
35. Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor10.1002/hep.21536 ↗
36. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human10.1517/17425255.2012.685159 ↗
37. Liver-cell patterning lab chip: mimicking the morphology of liver lobule tissue10.1039/c3lc50402f ↗
38. 3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip10.1039/C5LC00611B ↗
39. Bile acid signaling in liver metabolism and diseases10.1155/2012/754067 ↗
40. Pumpless microfluidic platform for drug testing on human skin equivalents10.1039/C4LC00999A ↗
41. Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device10.1063/1.3580753 ↗
42. Enhanced bile canaliculi formation enabling direct recovery of biliary metabolites of hepatocytes in 3D collagen gel microcavities10.1039/c2lc40046d ↗
43. Immunohistochemical evidence for hepatic progenitor cells in liver diseases10.1034/j.1600-0676.2002.01622.x ↗
44. Bioprinting perfusion-enabled liver equivalents for advanced organ-on-a-chip applications10.3390/genes9040176 ↗
45. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein10.1124/jpet.110.166991 ↗
46. Culture and in vitro hepatogenic differentiation of placenta‐derived stem cells, using placental extract as an alternative to serum10.1111/j.1365-2184.2010.00693.x ↗
47. Hepatocyte concentrations of indocyanine green reflect transfer rates across membrane transporters10.1111/bcpt.12671 ↗
48. Polymorphism of human cytochrome P450 enzymes and its clinical impact10.1080/03602530902843483 ↗
49. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting10.1073/pnas.1524510113 ↗
50. The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis10.3978/j.issn.2305-5839.2013.03.02 ↗
51. A hybrid co-culture model with endothelial cells designed for the hepatic tissue engineering10.1007/s10856-017-5950-3 ↗
52. Vascularized organoid engineered by modular assembly enables blood perfusion10.1073/pnas.0602740103 ↗
53. Nonprescription use of pain relievers by middle‐aged and elderly community‐living adults: national survey on drug use and health10.1111/j.1532-5415.2009.02306.x ↗
54. Acute liver necrosis following overdose of paracetamol10.1136/bmj.2.5512.497 ↗
55. Acetaminophen‐induced acute liver failure: results of a United States multicenter, prospective study10.1002/hep.20948 ↗